EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities

Jiejia Li, Liyun Wang, Xiaodan Zhang, Jianhua Shi, Yizhun Zhu iD, Han Wang, Xiangyang Zhu, Qing Zhu, Jia-Lie Luo

Biomolecules · 08.09.2025 · 15 (9) · 1290

DOI: 10.3390/biom15091290 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 08.09.2025. Verfasst von Jiejia Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, No. 9, Seyuan Road, Nantong 226001, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Nantong Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD), characterized by progressive cognitive decline and functional impairment, is the most prevalent cause of dementia, and it poses a significant socioeconomic and caregiving burden on patients, families, and healthcare systems. Notwithstanding comprehensive research, the precise causes underlying AD remain ambiguous. Evidence increasingly indicates that AD is a multifactorial and heterogeneous disease involving a mix of genetic and environmental factors. The amyloid-cascade hypothesis, neuroinflammation and immunity, vascular pathology, and oxidative stress all fulfill significant functions in the onset and development of AD. This review primarily examines the critical pathogenesis, key biomarkers, and novel therapeutic strategies of Alzheimer’s disease to inform future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansBiomarkersAnimalsOxidative StressAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkerpathogenesistherapeutic strategies

Substanzen

BiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • School of Pharmacy, Nantong University, No. 9, Seyuan Road, Nantong 226001, China.
  • Institute for Translational Neuroscience, Second Affiliated Hospital, Nantong University, Nantong 226001, China.
  • Centre for Neural Developmental and Degenerative Research, Nantong University, Nantong 226001, China.
  • Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macau, China.
  • School of Pharmacy, Macau University of Science and Technology, Macau, China.
  • Department for Neurology, Second Affiliated Hospital, Nantong University, Nantong 226001, China.

ORCID-Profile: Yizhun Zhu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Nantong Municipal Health Commission
  • Nantong First People’s Hospital
  • Macau Science and Technology Development fund
  • Shenzhen-Hong Kong-Macao Science and Technology Fund

Zitieren

APA

Li, J., Wang, L., Zhang, X., Shi, J., Zhu, Y., Wang, H., Zhu, X., Zhu, Q., & Luo, J. L. (2025). Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities. Biomolecules, 15(9), 1290. https://doi.org/10.3390/biom15091290

Vancouver

Li J, Wang L, Zhang X, Shi J, Zhu Y, Wang H, et al. Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities. Biomolecules. 2025;15(9):1290. doi:10.3390/biom15091290

BibTeX
@article{Li2025,
  author = {Li, Jiejia and Wang, Liyun and Zhang, Xiaodan and Shi, Jianhua and Zhu, Yizhun and Wang, Han and Zhu, Xiangyang and Zhu, Qing and Luo, Jia-Lie},
  title = {Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {1290},
  doi = {10.3390/biom15091290}
}
Kostenlos starten →